AZILECT.com
We are pleased to announce that AZILECT® was approved by the Food and Drug Administration and is
now available in pharmacies by prescription only. Please visit the AZILECT® Web site to learn more.
AZILECT® is indicated for the treatment of the signs and symptoms of Parkinson’s disease (PD) both as
initial therapy alone and to be added to levodopa later in the disease.
The effectiveness of AZILECT® was shown in patients with early PD who were receiving AZILECT® as initial therapy alone and who were not receiving any other
PD therapy. The effectiveness of AZILECT® as adjunct therapy was shown in patients with PD who were treated with levodopa.
Managing PD can be difficult, but with the right information you can help take control of the disease.
Check out AZILECT.com for:
- Information on AZILECT®.
- Find out if AZILECT® is right for you.
- Tools to help you track your symptoms.
- Special information for caregivers.